Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 301–400 of 1,011
Marine oils: the health benefits of n-3 fatty acids
Uauy, R., & Valenzuela, A. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00326-9 · Cited by 237
Latruffe, N., & Vamecq, J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81496-4 · Cited by 237
Camp, H. S., Tafuri, S. R., & Leff, T. (1999) · Endocrinology · doi:10.1210/endo.140.1.6457 · Cited by 230
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
Hong, F., Pan, S., Guo, Y., Xu, P., & Zhai, Y. (2019) · Molecules · doi:10.3390/molecules24142545 · Cited by 233
“It is well known that this receptor was discovered in murine animals [8], and was subsequently found in other species, such as frog [9], rat [10], human [11], and rabbit [12], and that it was a target for hypolipidemic fibrates [8].”
BackgroundTranscription coactivators for peroxisome proliferator-activated receptors
YU, S., & REDDY, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.01.008 · Cited by 222
The PPAR regulatory system in cardiac physiology and disease
FINCK, B. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.023 · Cited by 223
“PPARαwas initially identified for its role in mediating the hepatic peroxisome proliferative response to non-genotoxic rodent hepatocarcinogens [21], which are potent synthetic ligands for PPARα.”
BackgroundIII. Peroxisomal β-oxidation, PPARα, and steatohepatitis
Reddy, J. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1333 · Cited by 236
Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.
Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., & Wahli, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31420-5 · Cited by 233
The α1-Fetoprotein Locus Is Activated by a Nuclear Receptor of the Drosophila FTZ-F1 Family
Galarneau, L., Paré, J.-F., Allard, D., Hamel, D., Lévesque, L., Tugwood, J. D., Green, S., & Bélanger, L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3853 · Cited by 235
Self-citationZhang, B., Marcus, S. L., Sajjadi, F. G., Alvares, K., Reddy, J. K., Subramani, S., Rachubinski, R. A., & Capone, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7541 · Cited by 232
Drug repositioning: Progress and challenges in drug discovery for various diseases
Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232
“Previous studies have shown that [84,85] ligands that activate PPARg can be used as effective therapeutic strategies to inhibit ovarian cancer.”
Post-Translational Modifications of Nuclear Receptors and Human Disease
Anbalagan, M., Huderson, B., Murphy, L., & Rowan, B. G. (2012) · Nuclear Receptor Signaling · doi:10.1621/nrs.10001 · Cited by 211
“Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid homeostasis, energy metabolism, inflammatory responses and the induction of apoptosis [Issemann and Green, 1990; Rosen and Spiegelman, 2006].”
Peroxisome‐mitochondria interplay and disease
Schrader, M., Costello, J., Godinho, L. F., & Islinger, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9819-7 · Cited by 215
Torra, I. P., Gervois, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00009 · Cited by 231
Review of the Structural and Dynamic Mechanisms of PPAR γ Partial Agonism
Kroker, A. J., & Bruning, J. B. (2015) · PPAR Research · doi:10.1155/2015/816856 · Cited by 217
“While endogenous ligands of PPAR𝛾 include fatty acids and eicosanoids, synthetic full agonists of the receptor, including members of the thiazolidinedione (TZD) class, have been widely prescribed for the treatment of type II diabetes mellitus (T2DM).”
BackgroundFatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humans
Wanders, R. J. A., Komen, J., & Kemp, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07947.x · Cited by 218
Urinary Excretion of Fatty Acid-Binding Protein Reflects Stress Overload on the Proximal Tubules
Kamijo, A., Sugaya, T., Hikawa, A., Okada, M., Okumura, F., Yamanouchi, M., Honda, A., Okabe, M., Fujino, T., Hirata, Y., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63384-6 · Cited by 231
“Recently, it has been reported that L-FABP transports FFAs from the cytosol to the nucleus(39,40) and that L-FABP interacts with the nuclear protein peroxisome proliferator-activated receptors,(41) which is a nuclear target of FFAs and initiates the gene expression of enzymes involved in lipid metabolism.(42,43) L-FAB…”
BackgroundNuclear Receptors in Lipid Metabolism: Targeting the Heart of Dyslipidemia
Beaven, S. W., & Tontonoz, P. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131428 · Cited by 225
Chawla, A., & Lazar, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1786 · Cited by 227
Komar, C. M. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-41 · Cited by 219
Glucose Catabolism in Cancer Cells.
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16918 · Cited by 229
Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00234-1 · Cited by 225
Reversing adipocyte differentiation: Implications for treatment of obesity
Zhou, Y.-T., Wang, Z.-W., Higa, M., Newgard, C. B., & Unger, R. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2391 · Cited by 228
Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors
Lalloyer, F., & Staels, B. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179689 · Cited by 216
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Heaney, A. P., Fernando, M., Yong, W. H., & Melmed, S. (2002) · Nature Medicine · doi:10.1038/nm784 · Cited by 226
“gif" NDATA ITEM> ]> Peroxisome proliferator-activated receptor-γ (PPAR-γ), a member of the nuclear receptor superfamil”
Rosenfeld, J. M., Vargas, R., Xie, W., & Evans, R. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0421 · Cited by 223
INTRACELLULAR LIPID-BINDING PROTEINS AND THEIR GENES
Bernlohr, D. A., Simpson, M. A., Hertzel, A. V., & Banaszak, L. J. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.277 · Cited by 227
“There are multiple isoforms of PPAR in mice (α, γ , and δ) (133) and in Xenopus laevis (α, β, and γ ) (25, 46).”
Goto, T., Lee, J.-Y., Teraminami, A., Kim, Y.-I., Hirai, S., Uemura, T., Inoue, H., Takahashi, N., & Kawada, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011320 · Cited by 217
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
Guan, Y., Zhang, Y., Davis, L., & Breyer, M. D. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f1013 · Cited by 226
“Since the first PPAR (PPARa) was cloned from mouse liver (18), two additional PPAR genes have been recognized (8).”
BackgroundOmega-3 polyunsaturated fatty acid regulation of gene expression
Price, P. T., Nelson, C. M., & Clarke, S. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00002 · Cited by 222
Lazennec, G. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.1962 · Cited by 220
“PPARs were first shown to be activated by substances that induce peroxisome proliferation (5, 6).”
The pleiotropic functions of peroxisome proliferator-activated receptor γ
Debril, M.-B., Renaud, J.-P., Fajas, L., & Auwerx, J. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000145 · Cited by 220
“receptor activated by peroxisome proliferators [1].”
Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
Duez, H., van der Veen, J. N., Duhem, C., Pourcet, B., Touvier, T., Fontaine, C., Derudas, B., Baugé, E., Havinga, R., Bloks, V. W., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.035 · Cited by 212
The Peroxisome Proliferator‐activated Receptors: Ligands and Activatorsa
FORMAN, B. M., CHEN, J., & EVANS, R. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18621.x · Cited by 218
Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
Qi, C., Zhu, Y., & Reddy, J. K. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:187 · Cited by 216
Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E., & Wahli, W. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0036 · Cited by 214
“Human HeLa cells were transiently transfected using the phosphate calcium method with expression vectors for murine (m) PPAR (39), mPPAR (40), or mPPAR (41), the single PPRE-containing reporter plasmid AcoA.”
MethodLevak-Frank, S., Radner, H., Walsh, A., Stollberger, R., Knipping, G., Hoefler, G., Sattler, W., Weinstock, P. H., Breslow, J. L., & Zechner, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118145 · Cited by 218
Rottman, J. N., Widom, R. L., Nadal-Ginard, B., Mahdavi, V, & Karathanasis, S. K. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3814 · Cited by 216
Marine Glutathione S-Transferases
Blanchette, B., Feng, X., & Singh, B. R. (2007) · Marine Biotechnology · doi:10.1007/s10126-007-9034-0 · Cited by 214
“The A1 promoter, on the other hand, was shown to contain estrogen and peroxisomal proliferators response elements (EREs and PPREs), which are known to play a role in female sexual maturity and in fatty acid metabolism (Issemann and Green, 1990; Martinez et al., 1991).”
BackgroundFroment, P., Gizard, F., Defever, D., Staels, B., Dupont, J., & Monget, P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06667 · Cited by 212
“Since the discovery of PPARs in 1990 (Issemann & Green 1990), numerous functions have been attributed to these receptors.”
BackgroundBe Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the Road
Desvergne, B., Michalik, L., & Wahli, W. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0088 · Cited by 222
Targeting nuclear receptors for the treatment of fatty liver disease
Tanaka, N., Aoyama, T., Kimura, S., & Gonzalez, F. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.011 · Cited by 212
“To explain a mechanism of rapid and drastic changes following PP administration, the involvement of transcription factors was assumed and the first PPAR [later defined as PPARα (NR1C1)] was identified in 1990 (Issemann & Green, 1990).”
BackgroundYang, W.-L. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1379 · Cited by 218
“Compounds that activate PPARγ comprise a heterogeneous group that includes polyunsaturated fatty acids (8), the thiazolidinedione class of anti-diabetic drugs, such as troglitazone, pioglitazone, BRL49653 and ciglitazone (cig) (5,9, 10 ), and the nuclear prostanoid 15-deoxy-∆12,14-prostaglandin (PG) J2 (11).”
Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer Cells
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103779200 · Cited by 215
Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0322 · Cited by 215
“Treatment with peroxisome proliferators results in a short-term pleiotropic response that is manifest by liver hyperplasia and hypertrophy, proliferation of peroxisomes, and increases in oxidation of fatty acids through induction of genes encoding mitochondrial, peroxisomal, and microsomal fatty acid oxidation systems…”
BackgroundRole of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
Neve, B. P., Fruchart, J.-C., & Staels, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00430-5 · Cited by 211
Diascro, D. D., Vogel, R. L., Johnson, T. E., Witherup, K. M., Pitzenberger, S. M., Rutledge, S. J., Prescott, D. J., Rodan, G. A., & Schmidt, A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.96 · Cited by 210
“It was demonstrated that fatty acids and thiazolidinediones, agents that transactivate PPARs, promote adipocytic differentiation in myoblast cell lines, which express NUC-1/ PPARd but not PPARg or PPARa, and inhibit the formation of myotubes.”
BackgroundMethodInfluentialPPARs and the Cardiovascular System
Hamblin, M., Chang, L., Fan, Y., Zhang, J., & Chen, Y. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2280 · Cited by 207
“In rodent models, PPARa was shown to be activated by fibrates, hypolipidemic drugs that are involved in peroxisome proliferation and fatty acid oxidation (172).”
Vu-Dac, N., Gervois, P., Jakel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart-Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206
Oxidized phospholipids activate PPARα in a phospholipase A2‐dependent manner
Delerive, P., Furman, C., Teissier, E., Fruchart, J.-C., Duriez, P., & Staels, B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01364-8 · Cited by 199
Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208
Putative nuclear localization signals (NLS) in protein transcription factors
Boulikas, T. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550106 · Cited by 204
The peroxisome: still a mysterious organelle
Schrader, M., & Fahimi, H. D. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0396-9 · Cited by 191
“A well-known characteristic of peroxisomes is their inducibility by divergent chemicals and drugs which is mediated by the transcription factors referred to as “peroxisome proliferator activated receptors” (PPARs) (Issemann and Green 1990).”
BackgroundInfluentialMatsuda, M., & Shimomura, I. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9271-7 · Cited by 196
“PPARγ is a master regulator that plays a key role in the control of adipocyte-specific gene expression in combination with CCAAT/enhancer binding protein α during adipose differentiation [84].”
BackgroundCross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors
Forman, B. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.9.1253 · Cited by 199
Ide, T., Shimano, H., Yoshikawa, T., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Yatoh, S., Iizuka, Y., Tomita, S., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0191 · Cited by 199
“CMV or T7 promoter expression plasmid of mouse (m) PPAR (1–468, amino acid) (16) was prepared by PCR, and the cDNA was introduced into pCMV7 or pBluescript II SK vector, respectively.”
BackgroundMethodThe Role of IL‐1 and IL‐1Ra in Joint Inflammation and Cartilage Degradation
Jacques, C., Gosset, M., Berenbaum, F., & Gabay, C. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74016-x · Cited by 196
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Jay, M., & Ren, J. (2007) · Current Diabetes Reviews · doi:10.2174/157339907779802067 · Cited by 196
“They are liganddependent transcriptional regulators which heterodimerize with a retinoid X receptor and bind to peroxisome prolixferator-response element (PPRE) [3, 4 ]. PPARs may either activate or inhibit transcription and regulate activity of nuclear factors essential for immunomodulatory and inflammatory response…”
BackgroundBionaz, M., Chen, S., Khan, M. J., & Loor, J. J. (2013) · PPAR Research · doi:10.1155/2013/684159 · Cited by 195
“Initial characterization of PPARα (gene symbolPPARA in human and ruminants) in the adultmouse revealed that it was highly expressed in liver, kidney, and heart [4].”
BackgroundXu, Y., Romero, R., Miller, D., Kadam, L., Mial, T. N., Plazyo, O., Garcia-Flores, V., Hassan, S. S., Xu, Z., Tarca, A. L., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502055 · Cited by 199
“PPARg is a hormone nuclear receptor (106, 107) that binds lipid metabolites including eicosanoids, polyunsaturated fatty acids, and oxidized phospho-”
BackgroundInoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199
Kamijo, A., Kimura, K., Sugaya, T., Yamanouchi, M., Hikawa, A., Hirano, N., Hirata, Y., Goto, A., & Omata, M. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2003.08.001 · Cited by 200
Sundseth, S. S., & Waxman, D. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50613-5 · Cited by 202
Drug-metabolizing enzymes in ligand-modulated transcription
Nebert, D. W. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90434-0 · Cited by 203
The steroid receptor superfamily: mechanisms of diversity
Fuller, P. J. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1743440 · Cited by 200
Holden, P., & Tugwood, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220001 · Cited by 201
“It was shown to be highly expressed in rat and mouse and activated by a number of PPs (Issemann & Green 1990, Kliewer et al. 1994).”
BackgroundMethodLambe, K. G., & Tugwood, J. D. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0001u.x · Cited by 198
Gelman, L., Fruchart, J.-C., & Auwerx, J. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050345 · Cited by 199
Three Peroxisome Proliferator-Activated Receptor Isotypes from Each of Two Species of Marine Fish
Leaver, M. J., Boukouvala, E., Antonopoulou, E., Diez, A., Favre-Krey, L., Ezaz, M. T., Bautista, J. M., Tocher, D. R., & Krey, G. (2005) · Endocrinology · doi:10.1210/en.2004-1638 · Cited by 193
“responsible for peroxisomal proliferation in rodent liver (4).”
BackgroundBaillie, R. A., Takada, R., Nakamura, M., & Clarke, S. D. (1999) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80011-8 · Cited by 194
Wagner, K.-D., & Wagner, N. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.001 · Cited by 189
Peroxisome proliferator-activated receptor agonists
Willson, T. M., & Wahli, W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80015-4 · Cited by 198
Osumi, T., Wen, J.-K., & Hashimoto, T. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91645-s · Cited by 196
A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle
Minnich, A., Tian, N., Byan, L., & Bilder, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e270 · Cited by 192
“THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) is so named because of its initial identification as the molecular mediator of the peroxisome proliferation response to a number of chemical stimuli, including fibrates, in mice (15, 17).”
BackgroundPrieur, X., Coste, H., & Rodríguez, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301302200 · Cited by 194
Tang, H., & McLachlan, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1841 · Cited by 183
Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation
Scandiffio, R., Geddo, F., Cottone, E., Querio, G., Antoniotti, S., Gallo, M. P., Maffei, M. E., & Bovolin, P. (2020) · Nutrients · doi:10.3390/nu12113273 · Cited by 177
“PPARα (also called NR1C1) was later identified [76] as a new member of the steroid hormone receptor superfamily, that could be activated by different molecules, such as fatty acids and fibrates, a widely used class of hypolipidemic drugs.”
BackgroundStatins: a new insight into their mechanisms of action and consequent pleiotropic effects.
Jasińska-Stroschein, M., Owczarek, J., & Orszulak–Michalak, D. (2007) · PubMed · Cited by 235
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0823-5 · Cited by 191
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin
Shalev, A. (1996) · Endocrinology · doi:10.1210/en.137.10.4499 · Cited by 187
“m liver, mtestme, kidney and brown adipose tissue, while PPARy is found adipose tissue (3, 4).”
BackgroundHerb-Drug Interactions and Hepatotoxicity
Parvez, M. K., & Rishi, V. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190325141422 · Cited by 187
Fruchart, J.-C. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-82 · Cited by 189
“Three PPAR isoforms have been identified (PPARα, γ and δ), each encoded by a separate gene [25].”
BackgroundFission and proliferation of peroxisomes
Schrader, M., Bonekamp, N. A., & Islinger, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.014 · Cited by 189
“After the nuclear receptor Peroxisome Proliferator Activated Receptor α (PPARα), which belongs to the superfamily of steroid/ thyroid/retinoid receptors, was identified as the responsible mediator for changing the expression of peroxisomal genes [22–24], it was possible to unveil that unsaturated long chain fatty acid…”
BackgroundThieringer, R., Fenyk-Melody, J. E., Le Grand, C. B., Shelton, B. A., Detmers, P. A., Somers, E. P., Carbin, L., Moller, D. E., Wright, S. D., & Berger, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1046 · Cited by 193
Zhu, Y., Kan, L., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13510 · Cited by 187
Dose-dependent transitions in mechanisms of toxicity: case studies
SLIKKERJR, W., ANDERSEN, M., BOGDANFFY, M., BUS, J., COHEN, S., CONOLLY, R., DAVID, R., DOERRER, N., DORMAN, D., & GAYLOR, D. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.027 · Cited by 185
“From Issemann and Green (1990). Carnitine acetyltransferase activity in COS1 cells following activation of PPARa.”
BackgroundPPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M., & Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16575 · Cited by 184
“Introduction PPAR-γ, a member of the nuclear receptor superfamily (1, 2), functions as a transcription factor mediating ligand-dependent transcriptional regulation (3–5).”
BackgroundPleiotropic effects of statins: new therapeutic targets in drug design
Bedi, O., Dhawan, V., Sharma, P. L., & Kumar, P. (2016) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-016-1252-4 · Cited by 177
“Atorvastatin decreased cardiac Rac1 and RhoA activities and downregulated atrial natriuretic peptide, as well as myosin light chain 2V expression in spontaneously hypertensive rats (Issemann and Green 1990).”
BackgroundLiver regeneration versus direct hyperplasia
Columbano, A., & Shinozuka, H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.10.8751714 · Cited by 188
PPAR ? agonists stimulate oligodendrocyte differentiation in tissue culture
Saluja, I., Granneman, J. G., & Skoff, R. P. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<191::aid-glia1018>3.0.co;2-m · Cited by 200
“PPARs have been shown to be activated by peroxisome proliferators that include hypolipedemic drugs, herbicides, and other structurally related diverse compounds that induce peroxisome proliferation (Isseman and Green, 1990; Corton et al., 2000).”
BackgroundKuwata, H., Nakatani, Y., Murakami, M., & Kudo, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1733 · Cited by 187
Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
Lee, Y. K., Park, J. E., Lee, M., & Hardwick, J. P. (2018) · Liver Research · doi:10.1016/j.livres.2018.12.001 · Cited by 173
What lipodystrophies teach us about the metabolic syndrome
Mann, J. P., & Savage, D. B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129190 · Cited by 179
“Peroxisome proliferator–activated receptors (PPARs) α, δ, and γ were identified nearly 30 years ago (16).”
BackgroundLi, J.-L., Wang, Q.-Y., Luan, H.-Y., Kang, Z.-C., & Wang, C.-B. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-32 · Cited by 180
“PPAR-a is distributed in metabolically active tissues including liver, most prominently in hepatocytes [10,11].”
BackgroundIdentification of a subtype selective human PPARα agonist through parallel-array synthesis
Brown, P. J., Stuart, L. W., Hurley, K. P., Lewis, M. C., Winegar, D. A., Wilson, J. G., Wilkison, W. O., Ittoop, O. R., & Willson, T. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00188-3 · Cited by 177
Aldridge, T. C., Tugwood, J. D., & Green, S. (1995) · Biochemical Journal · doi:10.1042/bj3060473 · Cited by 182
Self-citationTakeda, K., Toda, K., Saibara, T., Nakagawa, M., Saika, K., Onishi, T., Sugiura, T., & Shizuta, Y. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760237 · Cited by 182
Phosphorylation of PPARs: from molecular characterization to physiological relevance
Diradourian, C., Girard, J., & Pégorier, J.-P. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.010 · Cited by 178
La Paglia, L., Listì, A., Caruso, S., Amodeo, V., Passiglia, F., Bazan, V., & Fanale, D. (2017) · PPAR Research · doi:10.1155/2017/8187235 · Cited by 174
p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor α
Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33435 · Cited by 176
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.